Nils Lindner
Papers
2
Total Citations
38
H-Index
2
About
Nils Lindner is pioneering the intersection of bioprinting and automation to revolutionize pharmaceutical testing. His research focuses on developing high-scale, robotic-assisted platforms for the automated production of vascularized organs-on-a-chip (OOCs). Lindner’s major contribution lies in solving the critical bottleneck of scalability: while OOCs have proven superior to conventional models in mimicking human physiology, their manual fabrication has hindered commercialization. His work integrates 3D bioprinting with robotic handling systems to enable the reproducible, high-throughput manufacturing of these complex devices. His most-cited paper (2024, 31 citations) introduces a platform for the automated production of vascularized OOCs, while a subsequent study (7 citations) details the robotic manipulation system essential for industrial-scale bioproduction. By addressing both biological complexity and manufacturing feasibility, Lindner is paving the way for OOCs to become a standard tool in drug development and personalized medicine. His achievements represent a critical step toward closing the gap between lab-based tissue engineering and profitable, real-world biomedical applications.
Research Focus
Key Achievements
Top Papers
- 1
- 2